Sweden · Delayed Price · Currency is SEK ODI Pharma AB Statistics
Total Valuation
ODI Pharma AB has a market cap or net worth of SEK 41.43 million. The enterprise value is 38.04 million.
| Market Cap | 41.43M |
| Enterprise Value | 38.04M |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ODI Pharma AB has 18.33 million shares outstanding. The number of shares has decreased by -1.14% in one year.
| Current Share Class | 18.33M |
| Shares Outstanding | 18.33M |
| Shares Change (YoY) | -1.14% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 90.61% |
| Owned by Institutions (%) | n/a |
| Float | 1.72M |
Valuation Ratios
The trailing PE ratio is 20.84.
| PE Ratio | 20.84 |
| Forward PE | n/a |
| PS Ratio | 1.26 |
| PB Ratio | 17.44 |
| P/TBV Ratio | 17.44 |
| P/FCF Ratio | 9.05 |
| P/OCF Ratio | 9.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.16, with an EV/FCF ratio of 8.31.
| EV / Earnings | 19.14 |
| EV / Sales | 1.16 |
| EV / EBITDA | 15.16 |
| EV / EBIT | 15.19 |
| EV / FCF | 8.31 |
Financial Position
The company has a current ratio of 1.81
| Current Ratio | 1.81 |
| Quick Ratio | 1.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 4.15 |
Financial Efficiency
Return on equity (ROE) is 141.98% and return on invested capital (ROIC) is 111.82%.
| Return on Equity (ROE) | 141.98% |
| Return on Assets (ROA) | 31.59% |
| Return on Invested Capital (ROIC) | 111.82% |
| Return on Capital Employed (ROCE) | 105.44% |
| Weighted Average Cost of Capital (WACC) | 8.59% |
| Revenue Per Employee | 32.92M |
| Profits Per Employee | 1.99M |
| Employee Count | 1 |
| Asset Turnover | 6.64 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ODI Pharma AB has paid 24 in taxes.
| Income Tax | 24 |
| Effective Tax Rate | 0.00% |
Stock Price Statistics
The stock price has increased by +60.28% in the last 52 weeks. The beta is 0.79, so ODI Pharma AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +60.28% |
| 50-Day Moving Average | 2.42 |
| 200-Day Moving Average | 3.01 |
| Relative Strength Index (RSI) | 45.28 |
| Average Volume (20 Days) | 11,037 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ODI Pharma AB had revenue of SEK 32.92 million and earned 1.99 million in profits. Earnings per share was 0.11.
| Revenue | 32.92M |
| Gross Profit | 10.27M |
| Operating Income | 2.50M |
| Pretax Income | 1.99M |
| Net Income | 1.99M |
| EBITDA | 2.51M |
| EBIT | 2.50M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 3.39 million in cash and no debt, with a net cash position of 3.39 million or 0.18 per share.
| Cash & Cash Equivalents | 3.39M |
| Total Debt | n/a |
| Net Cash | 3.39M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 2.38M |
| Book Value Per Share | 0.13 |
| Working Capital | 2.36M |
Cash Flow
| Operating Cash Flow | 4.58M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4,650 |
| Net Borrowing | -2.79M |
| Free Cash Flow | 4.58M |
| FCF Per Share | 0.25 |
Margins
Gross margin is 31.20%, with operating and profit margins of 7.61% and 6.04%.
| Gross Margin | 31.20% |
| Operating Margin | 7.61% |
| Pretax Margin | 6.04% |
| Profit Margin | 6.04% |
| EBITDA Margin | 7.62% |
| EBIT Margin | 7.61% |
| FCF Margin | 13.90% |
Dividends & Yields
ODI Pharma AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.14% |
| Shareholder Yield | 1.14% |
| Earnings Yield | 4.80% |
| FCF Yield | 11.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |